Status:
COMPLETED
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand
Lead Sponsor:
AstraZeneca
Conditions:
Upper GIT Symptoms
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective , epidemiological, multi-centre, phase IV study, approximately 5,000 patients who suffer with upper gastrointestinal tract symptoms. Each patient will be assessed for GERD with G...
Eligibility Criteria
Inclusion
- Provision of informed consent prior to any study specific procedures
- Female or male aged at least 18 years
- Patient must be having symptoms suggestive of upper gastrointestinal tract symptoms such as heart burn/ regurgitation
Exclusion
- Involvement in the planning and /or conduct of the study (applies to both AstraZeneca staff and /or staff at study site
- Participation in a clinical study(excluding non-interventional study or registry) during the last 3 months
Key Trial Info
Start Date :
December 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
4108 Patients enrolled
Trial Details
Trial ID
NCT00999063
Start Date
December 1 2009
End Date
February 1 2011
Last Update
March 31 2011
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Bangkok Noi, Bangkok, Thailand
2
Research Site
Muang, Bangkok, Thailand
3
Research Site
Pathumwan, Bangkok, Thailand
4
Research Site
Rajthevee, Bangkok, Thailand